Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse
10.3760/cma.j.issn.0529-567x.2011.02.005
- VernacularTitle:经阴道网片植入手术治疗盆腔器官脱垂的临床分析
- Author:
Jinsong HAN
;
Kun ZHANG
;
Fuli ZHU
;
Ying YAO
;
Huamao LIANG
;
Lifei ZHOU
;
Hongyan GUO
- Publication Type:Journal Article
- Keywords:
Uterine prolapse;
Gynecologic surgical procedures;
Treatment outcome;
Quality of life
- From:
Chinese Journal of Obstetrics and Gynecology
2011;46(2):101-104
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate clinical outcome and complications of mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse. Methods From Feb 2007 to Jan 2009, meshaugmented vaginal reconstructive surgery were performed on 66 women with pelvic organ prolapse stage Ⅲ-Ⅳ. Pre and postoperative symptoms, pelvic organ prolapse quantitation (POP-Q) stage and pelvic floor distress inventory-short form 20 (PFDI-20) measurements were studied to assess anatomic and quality-of-life outcome. Operative complications were also analyzed. Results Totally 65 patients underwent successful surgeries. The rate of follow-up was 97% (63/65) with a median follow-up of 17. 2 months. Subjective cure rate and objective cure rate were both 97% (61/63) at 6 and 12 months after surgeries, 51 women completed PFDI-20 measurements and scores were 102 ± 50 before surgery, 16 ± 21 at 6 months and 15 ± 20 at 12 months. It reached statistical difference when scores were compared before and after surgeries ( P <0. 05). Among 66 patients, 2 patients underwent organ injuries, 2 had recurrent prolapse, 4 had meshrelated complications and 1 had severe de novo stress urinary incontinence. Six patients underwent second surgery. Conclusions Mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapsed brought satisfied clinical outcome. The incidence of mesh-related complications was low and secondary operative interventions were effective.